This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2015 Apr;32(4):119.

doi: 10.1007/s12032-015-0482-5.

Erratum to: single-agent bevacizumab is an effective treatment in recurrent glioblastoma

Ilhan Hacibekiroglu¹, Hilmi Kodaz, Bulent Erdogan, Esma Turkmen, Melike Ozcelik, Asim Esenkaya, Haci Mehmet Saygi, Sernaz Uzunoglu, Irfan Cicin

Affiliations

PMID: 25782869
DOI: 10.1007/s12032-015-0482-5

Published Erratum

Erratum to: single-agent bevacizumab is an effective treatment in recurrent glioblastoma

Ilhan Hacibekiroglu et al. Med Oncol. 2015 Apr.

. 2015 Apr;32(4):119.

doi: 10.1007/s12032-015-0482-5.

Authors

Ilhan Hacibekiroglu¹, Hilmi Kodaz, Bulent Erdogan, Esma Turkmen, Melike Ozcelik, Asim Esenkaya, Haci Mehmet Saygi, Sernaz Uzunoglu, Irfan Cicin

Affiliation

¹ Department of Medical Oncology, Faculty of Medicine, Trakya University, 22030, Edirne, Turkey, ilhanhbo@hotmail.com.

PMID: 25782869
DOI: 10.1007/s12032-015-0482-5

No abstract available

PubMed Disclaimer

Erratum for

Single-agent bevacizumab is an effective treatment in recurrent glioblastoma.
Hacibekiroglu I, Kodaz H, Erdogan B, Turkmen E, Ozcelik M, Esenkaya A, Saygi HM, Uzunoglu S, Cicin I. Hacibekiroglu I, et al. Med Oncol. 2015 Feb;32(2):460. doi: 10.1007/s12032-014-0460-3. Epub 2015 Jan 9. Med Oncol. 2015. PMID: 25572814

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer